Agency Forms Undergoing Paperwork Reduction Act Review, 70189-70190 [2014-27850]
Download as PDF
<![CDATA[
Federal Register / Vol. 79, No. 227 / Tuesday, November 25, 2014 / Notices
The MEPS–HC was last approved by
OMB on December 20th, 2012 and will
expire on December 31, 2015. The OMB
control number for the MEPS–HC is
0935–0118. All of the supporting
documents for the current MEPS–HC
can be downloaded from OMB’s Web
site at. https://www.reginfo.gov/public/
do/PRAViewDocument?ref_nbr=2012090935-001.
The MEPS is a multi-purpose survey.
In addition to collecting data to yield
annual estimates for a variety of
measures related to health care use and
expenditures, the MEPS also provides
estimates of measures related to health
status, consumer assessment of health
care, health insurance coverage,
demographic characteristics,
employment and access to health care
indicators. Estimates can be provided
for individuals, families and population
subgroups of interest. Data from the
MEPS–HC are intended for a number of
annual reports required to be produced
by the Agency, including the National
Health Care Quality Report and the
National Health Care Disparities Report.
AHRQ proposes to make the following
changes to questions asked of
respondents:
wreier-aviles on DSK4TPTVN1PROD with NOTICES
Additions
Closing—questions pertaining to
respondent email and administration
status of the Preventive Care selfadministered questionnaire;
Re-enumeration—addition of
questions pertaining to educational
level attainment and the determination
of institutional status;
Provider Probes—determination if
health care was received in an overnight
facility; and
Health Insurance—questions were
added regarding interaction with the
health insurance marketplace,
enrollment through state health
insurance exchanges, the extent of
subsidized health insurance, monthly
premiums, health insurance metal plan
names, and medical debt.
Preventive Care—a field test will be
conducted to assess response lost
through self-administration.
Deletions
Questions were removed from the
following sections: Access to Care,
Medical Conditions, Charge Payment,
Child Preventive Health, Disability
Days, Emergency Room, Employment,
Health Status, Health Insurance,
Hospital Stay, Income, Medical Provider
Visits, Outpatient Departments, and
Satisfaction with Health Plan.
Questions were removed to reduce
burden and redundancy, and additional
questions were removed due to
VerDate Sep<11>2014
14:41 Nov 24, 2014
Jkt 235001
difficulty in respondent interpretation,
low frequency in response or minimal
variation, and limited ability of
respondent to respond accurately.
Estimated Annual Respondent Burden
There are no changes to the current
burden estimates.
Estimated Annual Costs to the Federal
Government
There are no changes to the current
cost estimates.
Request for Comments
In accordance with the Paperwork
Reduction Act, comments on AHRQ’s
information collection are requested
with regard to any of the following: (a)
Whether the proposed collection of
information is necessary for the proper
performance of AHRQ health care
research and health care information
dissemination functions, including
whether the information will have
practical utility; (b) the accuracy of
AHRQ’s estimate of burden (including
hours and costs) of the proposed
collection(s) of information; (c) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(d) ways to minimize the burden of the
collection of information upon the
respondents, including the use of
automated collection techniques or
other forms of information technology.
Comments submitted in response to
this notice will be summarized and
included in the Agency’s subsequent
request for OMB approval of the
proposed information collection. All
comments will become a matter of
public record.
Dated: November 13, 2014.
Richard Kronick,
Director.
[FR Doc. 2014–27687 Filed 11–24–14; 8:45 am]
BILLING CODE 4160–90–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–15–14ARR]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
70189
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencies estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Written
comments and/or suggestions regarding
the items contained in this notice
should be directed to the Attention:
CDC Desk Officer, Office of Management
and Budget, Washington, DC 20503 or
by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Proposed Project
Drug Overdose Response Investigation
(DORI) Data Collections—New—
National Center for Injury Prevention
and Control (NCIPC), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
State and local health authorities
frequently call upon CDC’s National
Center for Injury Prevention and Control
(NCIPC) to assist in their response to
urgent public health problems resulting
from drug use, misuse, abuse, and
overdose. When called, NCIPC supports
the states and local health authorities by
conducting Drug Overdose Response
Investigations (DORI), which entails a
rapid and flexible epidemiological
response. Urgent requests, such as
DORIs, depend on the time and
resources available, number of persons
involved, and other circumstances
unique to the urgent conditions at hand,
and usually involve the development of
procedures, specific data collection
E:\FR\FM\25NON1.SGM
25NON1
70190
Federal Register / Vol. 79, No. 227 / Tuesday, November 25, 2014 / Notices
instruments, and the collection of
critical data.
This request is for a new generic
approval to conduct information
collections during DORIs. A three-year
clearance is requested to ensure: (1)
Rapid deployment of data collection
tools and (2) timely information
collection of vital information. Of
particular interest is response to
increasing trends in, or changing
characteristics of, overdose from
prescription drugs (with a special
interest in opioid analgesics such as
oxycodone or methadone;
benzodiazepines such as alprazolam)
and/or illicit drugs (e.g., heroin).
Specifically, this request covers
investigative collections with the
following aims: (1) To understand
sudden increases in drug use and
misuse associated with fatal and
nonfatal overdoses; (2) to understand
the drivers and risk factors associated
with those trends; and (3) to identify the
groups most affected. This will allow
CDC to effectively advise states on
recommended actions to control local
epidemics. Thus, the ultimate goals of
these collections are to minimize
adverse health consequences, provide
epidemiological data collection support
to the states and, based on the findings
from the investigation, appropriately
assist with implementation of
prevention and control measures.
Data is collected by epidemiologists,
psychologists, medical professionals,
subject matter experts, and
biostatisticians. Examples of data
collection modes that may be employed
during DORIs include: Archival record
abstractions and reviews, face-to-face
interviews, telephone interviews, webbased questionnaires, and selfadministered questionnaires.
For example, information collected
through archival chart review from
hospitals and medical examiners could
include demographics, drug use history,
reported medical and mental health
conditions, place of overdose, place of
death, drug paraphernalia on the scene,
mode of administration, observers
present, naloxone administration,
hospital admittance, autopsy findings,
and toxicology results. Information
collected through interviews with
representatives from agencies involved
in preventing, intervening, or
responding to drug overdose could
include professional history, personal
experience with drug overdose cases or
investigations, prevention or
intervention efforts engaged in, and
perceptions of characteristics of, or
changes in drug overdose cases (e.g.,
transition from opioids to heroin;
increasing or decreasing rates).
Collection of information from nonfatal
overdose victims, and friends and
family of overdose victims could
include substance use history,
prescription drug history, number of
providers and pharmacies used, pain
history, co-occurring health conditions
(e.g., abnormal snoring indicative of
respiratory depression), mental health
conditions (e.g., depression, anxiety
disorders), enrollment in drug treatment
programs, sources of drugs, route of
drug administration, and criminal
history. Finally, collection of spatial
information could be obtained through
city, county, and state government
agencies to determine structural and
environmental factors associated with
location of overdose deaths.
Respondent type will also vary by
investigation, but will include
organizations typically involved in
prevention, intervention, and response
to drug overdose (e.g., public health,
law enforcement authorities, health
systems, and community organizations).
Respondents also may include victims
of non-fatal drug overdoses, as well as
family and friends of victims.
During a DORI, data is collected once,
with the rare need for follow-up. There
are no costs to respondents other than
their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondent
Form name
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
Drug Overdose Response Investigation Participants.
Drug Overdose Response Investigation Data
Collection Instruments.
2,700
1
.5
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2014–27850 Filed 11–24–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
wreier-aviles on DSK4TPTVN1PROD with NOTICES
Centers for Disease Control and
Prevention
[30Day–15–0913]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
VerDate Sep<11>2014
14:41 Nov 24, 2014
Jkt 235001
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencies estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Written
comments and/or suggestions regarding
the items contained in this notice
should be directed to the Attention:
CDC Desk Officer, Office of Management
and Budget, Washington, DC 20503 or
by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
E:\FR\FM\25NON1.SGM
25NON1
]]>Agencies
[Federal Register Volume 79, Number 227 (Tuesday, November 25, 2014)]
[Notices]
[Pages 70189-70190]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-27850]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-15-14ARR]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) has submitted
the following information collection request to the Office of
Management and Budget (OMB) for review and approval in accordance with
the Paperwork Reduction Act of 1995. The notice for the proposed
information collection is published to obtain comments from the public
and affected agencies.
Written comments and suggestions from the public and affected
agencies concerning the proposed collection of information are
encouraged. Your comments should address any of the following: (a)
Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility; (b) Evaluate the
accuracy of the agencies estimate of the burden of the proposed
collection of information, including the validity of the methodology
and assumptions used; (c) Enhance the quality, utility, and clarity of
the information to be collected; (d) Minimize the burden of the
collection of information on those who are to respond, including
through the use of appropriate automated, electronic, mechanical, or
other technological collection techniques or other forms of information
technology, e.g., permitting electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to omb@cdc.gov. Written comments and/or
suggestions regarding the items contained in this notice should be
directed to the Attention: CDC Desk Officer, Office of Management and
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written
comments should be received within 30 days of this notice.
Proposed Project
Drug Overdose Response Investigation (DORI) Data Collections--New--
National Center for Injury Prevention and Control (NCIPC), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
State and local health authorities frequently call upon CDC's
National Center for Injury Prevention and Control (NCIPC) to assist in
their response to urgent public health problems resulting from drug
use, misuse, abuse, and overdose. When called, NCIPC supports the
states and local health authorities by conducting Drug Overdose
Response Investigations (DORI), which entails a rapid and flexible
epidemiological response. Urgent requests, such as DORIs, depend on the
time and resources available, number of persons involved, and other
circumstances unique to the urgent conditions at hand, and usually
involve the development of procedures, specific data collection
[[Page 70190]]
instruments, and the collection of critical data.
This request is for a new generic approval to conduct information
collections during DORIs. A three-year clearance is requested to
ensure: (1) Rapid deployment of data collection tools and (2) timely
information collection of vital information. Of particular interest is
response to increasing trends in, or changing characteristics of,
overdose from prescription drugs (with a special interest in opioid
analgesics such as oxycodone or methadone; benzodiazepines such as
alprazolam) and/or illicit drugs (e.g., heroin).
Specifically, this request covers investigative collections with
the following aims: (1) To understand sudden increases in drug use and
misuse associated with fatal and nonfatal overdoses; (2) to understand
the drivers and risk factors associated with those trends; and (3) to
identify the groups most affected. This will allow CDC to effectively
advise states on recommended actions to control local epidemics. Thus,
the ultimate goals of these collections are to minimize adverse health
consequences, provide epidemiological data collection support to the
states and, based on the findings from the investigation, appropriately
assist with implementation of prevention and control measures.
Data is collected by epidemiologists, psychologists, medical
professionals, subject matter experts, and biostatisticians. Examples
of data collection modes that may be employed during DORIs include:
Archival record abstractions and reviews, face-to-face interviews,
telephone interviews, web-based questionnaires, and self-administered
questionnaires.
For example, information collected through archival chart review
from hospitals and medical examiners could include demographics, drug
use history, reported medical and mental health conditions, place of
overdose, place of death, drug paraphernalia on the scene, mode of
administration, observers present, naloxone administration, hospital
admittance, autopsy findings, and toxicology results. Information
collected through interviews with representatives from agencies
involved in preventing, intervening, or responding to drug overdose
could include professional history, personal experience with drug
overdose cases or investigations, prevention or intervention efforts
engaged in, and perceptions of characteristics of, or changes in drug
overdose cases (e.g., transition from opioids to heroin; increasing or
decreasing rates). Collection of information from nonfatal overdose
victims, and friends and family of overdose victims could include
substance use history, prescription drug history, number of providers
and pharmacies used, pain history, co-occurring health conditions
(e.g., abnormal snoring indicative of respiratory depression), mental
health conditions (e.g., depression, anxiety disorders), enrollment in
drug treatment programs, sources of drugs, route of drug
administration, and criminal history. Finally, collection of spatial
information could be obtained through city, county, and state
government agencies to determine structural and environmental factors
associated with location of overdose deaths.
Respondent type will also vary by investigation, but will include
organizations typically involved in prevention, intervention, and
response to drug overdose (e.g., public health, law enforcement
authorities, health systems, and community organizations). Respondents
also may include victims of non-fatal drug overdoses, as well as family
and friends of victims.
During a DORI, data is collected once, with the rare need for
follow-up. There are no costs to respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondent Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
Drug Overdose Response Investigation Drug Overdose Response 2,700 1 .5
Participants. Investigation Data
Collection Instruments.
----------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2014-27850 Filed 11-24-14; 8:45 am]
BILLING CODE 4163-18-P
